Induction of T lymphocyte responses to dengue virus by a candidate tetravalent live attenuated dengue virus vaccine

Vaccine

Volumn 19, Issue 32, 2001, Pages 4694-4699

  Rothman, Alan L ^a   Kanesa Thasan, Niranjan ^b   West, Kim ^a   Janus, Jurand ^a   Saluzzo, Jean Francois ^c   Ennis, Francis A ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^c SANOFI PASTEUR   (France)

Author keywords

Cytotoxic T lymphocyte; Dengue; Interferon

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; DENGUE VACCINE; GAMMA INTERFERON; INTERLEUKIN 4; LIVE VACCINE;

ARTICLE; CELL PROLIFERATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DENGUE; DENGUE VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; INFECTION PREVENTION; NORMAL HUMAN; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; SEROTYPE; STIMULATION; T LYMPHOCYTE;

ANTIBODIES, VIRAL; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CULTURE MEDIA, CONDITIONED; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; DENGUE VIRUS; HUMANS; IMMUNOLOGIC MEMORY; INTERFERON TYPE II; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; NEUTRALIZATION TESTS; T-LYMPHOCYTES, CYTOTOXIC; VACCINATION; VACCINES, ATTENUATED; VACCINIA VIRUS; VARIATION (GENETICS); VIRAL VACCINES;

EID: 0035860631     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00236-5     Document Type: Article

References (14)

1. Dengue and dengue haemorrhagic fever
2. A prospective study of dengue infections in Bangkok
3. Risk factors in dengue shock syndrome
4. Virulence of a live dengue virus vaccine candidate: A possible new marker of dengue virus attenuation
5. Dengue 2 vaccine: Dose response in volunteers in relation to yellow fever immune status
6. Live attenuated tetravalent dengue vaccine
7. Dengue virus-specific memory T cell responses in human volunteers receiving a live attenuated dengue virus type 2 candidate vaccine
8. Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur, AP) in human volunteers
9. A plaque reduction test for dengue virus neutralizing antibodies
10. Human T cell responses to dengue virus antigens. Proliferative responses and interferon gamma production
11. Impaired T cell proliferation in acute dengue infection
12. Dominant recognition by human CD8+ cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a
13. Predominance of HLA-restricted CTL responses to serotype crossreactive epitopes on nonstructural proteins after natural dengue virus infections
14. Dengue virus-specific human CD4+ T-lymphocyte responses in a recipient of an experimental live-attenuated dengue virus type 1 vaccine: Bulk culture proliferation, clonal analysis, and precursor frequency determination